Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial
2021 · British Journal of Cancer · 69 citations
https://doi.org/10.1038/s41416-021-01471-1
M
Markus Weiler
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
5.6K
Citations
39
h-index
78
i10-index
Markus Weiler is an academic researcher from University of Freiburg. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Neurogenetic and Muscular Disorders Research & Amyloidosis: Diagnosis, Treatment, Outcomes. The author has an h-index of 39, co-authored 133 publications.
ORCID: 0000-0002-8942-7662Papers by this author
worksLong-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
2024 · The Lancet Regional Health - Europe · 56 citations
https://doi.org/10.1016/j.lanepe.2024.100862
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
2024 · JAMA Pediatrics · 50 citations
https://doi.org/10.1001/jamapediatrics.2024.0492
Comparative assessment of clinical rating scales in Wilson’s disease
2017 · BMC Neurology · 42 citations
https://doi.org/10.1186/s12883-017-0921-3
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
2022 · Orphanet Journal of Rare Diseases · 39 citations
https://doi.org/10.1186/s13023-022-02547-8
Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
2023 · Journal of Neurology · 26 citations
https://doi.org/10.1007/s00415-023-11787-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat